Investor Presentation

INVESTOR PITCH DECK Performance Review & Business Results FY26-27 www.syschem.in REPORT OVERVIEW This presentation provides a structured overview of the company’s performance, achievements, and strategic progress over the reporting period. It highlights key financial and operational insights. The objective is to ensure transparency and support informed decision-making. 2nd QUARTER RESULTS FY26-27 VISION & MISSION Our Mission Our Vision The company aims to become one of India’s To become a leading and trusted global leading manufacturers of APIs and partner in the API industry by providing high- pharmaceutical intermediates by creating quality, innovative, and sustainable solutions. long-term value for all stakeholders through Syschem India Limited is committed to innovation, operational excellence, and scientific excellence, regulatory compliance, responsible manufacturing. It is committed to and creating long-term value for customers, fostering a culture of collaboration, growth, employees, and society through ethical and and safety at every level while continuously environmentally responsible practices. investing in R&D and quality systems to meet evolving customer and regulatory requirements. ~INNOVATING TODAY FOR A HEALTHIER TOMORROW 2nd QUARTER RESULTS FY26-27 HIGHLIGHTS The company achieved strong performance across core business areas. Revenue for the quarter witnessed a moderation compared to the previous Revenue quarter, primarily reflecting the moderation challenging market environment and cautious customer demand amid global economic uncertainties. Despite the decline in revenue, the Company maintained strong operational efficiency through disciplined cost 03. 02. management, optimized production planning, and effective strategic execution. Continued focus on operational excellence, prudent resource utilization, and customer engagement enabled the Company to sustain business continuity and strengthen its foundation for future Effective strategic Operational growth as market conditions improve. execution efficiency 2nd QUARTER RESULTS FY26-27 01 Amoxicillin T/H Amoxicillin is a widely used antibiotic belonging to the penicillin group of antibiotics. 02 Ampicillin T/H Ampicillin is a type of antibiotic that is commonly used to treat bacterial infections. Flucloxacillin Sod. Flucloxacillin is a type of antibiotic that is commonly used to treat bacterial infections KEY PRODUCTS Cloxacillin Sod. Cloxacillin is a type of antibiotic that is commonly used to treat bacterial infections. Cephalexin Cephalexin is a type of antibiotic that is commonly used to treat bacterial infections. 06 Cephadroxil 2nd QUARTER RESULTS FY26-27 GROWTH & CAPACITY EXPANSION MMMAAANNNUUUFFFAAACCCTTTUUURRRIIINNNGGG EEEXXXPPPAAANNNSSSIIIOOONNN WWWOOORRRKKKFFFOOORRRCCCEEE GGGRRROOOWWWTTTHHH QQQUUUAAALLLIIITTTYYY CCCOOOMMMPPPLLLIIIAAANNNCCCEEE Development of dedicated Our team has grown significantly, Focused on achieving Amoxicillin and other products like bringing together experienced and WHO-GMP certification to highly qualified professionals. Cloxacillin sodium , Flucloxacillin strengthen global quality Backed by extensive audit expertise, sodium and Dicloxacillin sodium standards and regulatory we deliver high-quality services plants to enhance manufacturing compliance. with professionalism, efficiency, and capacity and support future a strong commitment to excellence. business growth. Investor Presentation, 2026 FINANCIAL SUMMARY 2nd QUARTER RESULTS FY26-27 Metric Result Trend Revenue Moderate Moderate Profit/Loss Profit/Loss Net Deficit Expenses Controlled Stable Cash Flow Stable Controlled 2nd QUARTER RESULTS FY26-27 PERFORMANCE CYCLE FINANCIALS Figures in Rs.Lakhs Figures in Rs.Lakhs EBITDA June FY25-26 600 12676 March FY25-26 REVENUE 24831 300 200 June FY26-27 12600 0 -200 June FY25-26 March FY25-26 June FY26-27 March FY25-26 June FY26-27 June FY25-26 2nd QUARTER RESULTS FY26-27 FINANCIALS EBITDA Figures in Rs.Lakhs Figures in Rs.Lakhs March FY25-26 551 June FY25-26 247 4TH QUARTER 1ST QUARTER FY25-26 FY25-26 June FY26-27 38 June FY26-27 38 1ST QUARTER 1ST QUARTER FY26-27 FY26-27 June FY26-27 38 June FY26-27 38 2nd QUARTER RESULTS FY26-27 FINANCIALS Figures in Rs.Lakhs Figures in Rs.Lakhs 0 500 0 March FY25-26 560 June FY25-26 167 June FY26-27 -145 June FY26-27 -145 2nd QUARTER RESULTS FY26-27 FINANCIALS Figures in Rs.Lakhs Figures in Rs.Lakhs -100 -50 -100 -200 March FY25-26 June FY26-27 -150 June FY25-26 June FY26-27 2nd QUARTER RESULTS FY26-27 During the quarter, the Company experienced a relatively softer financial performance compared to the previous quarter. EBITDA moderated, and Profit Before Tax (PBT) was impacted primarily by significant fluctuations in BUSINESS foreign exchange rates and heightened volatility in global financial markets arising from ongoing geopolitical and economic uncertainties. Despite these PERFORMANCE near-term challenges, the Company's core business operations remained stable, and management continues to focus on operational efficiency, cost optimization, and strengthening its market position to support improved performance in the coming quarters. CCCCUUUUSSSSTTTTOOOOMMMMEEEERRRRSSSS 2nd QUARTER RESULTS FY26-27 GGGGEEEEOOOOGGGGRRRRAAAAPPPPHHHHIIIICCCC EEEEXXXXPPPPAAAANNNNSSSSIIIIOOOONNNN Afghanistan China Bangladesh Nepal Thailand Cambodia Uganda Kenya Congo Sri Lanka Nigeria Rwanda Our growing presence across key domestic states and international markets reflects the strength of our distribution network and customer relationships. We remain focused on expanding into strategic geographies while delivering consistent quality and reliable supply to customers worldwide. 2nd QUARTER RESULTS FY26-27 EEEESSSSGGGG IIIINNNNIIIITTTTIIIIAAAATTTTIIIIVVVVEEEESSSS • Efficient Utilities & Zero Liquid Discharge • Carbon Footprint • Eco-friendly Packaging Green T echnologies (ZLD) Reduction E n v i r o n m e n t •Woman • Healthcare Initiatives • Fair Trade Practices • Gender Diversity Empowerment S o c i a l • Risk Management • Adherence to Regulatory • Board Composition • Stakeholder Governance Compliance and Governance Responsibility G o v e r n a n c e 2nd QUARTER RESULTS FY26-27 ~ I N N O V A T I N G T O D A Y F O R A H E A L T H I E R T O M O R R O W THANK YOU For further information contact www.syschem.in Head Office : 825, FF, NAC Manimajra , Chandigarh-161001 Factory at : Village Bargodam, Tehsil Kalka, Dist. Panchkula, Haryana-133302 0172-5070471 info@syschem.in